In addition, patients who undergo genetic testing may learn they are at risk for a cancer that has limited or no effectual screening and prevention measures or that invasive surgery (e.g., prophylactic total gastrectomy for CDH1-mutation carriers or bilateral salpingo-oophorectomy for BRCA1/2-mutation carriers) is their greatest chance to decrease cancer risk. This evidence concerns the gene BRCA1 and cancer.